Background: Hypertrophic (HCM) and dilated (DCM) cardiomyopathies result from sarcomeric protein mutations, including cardiac troponin T (cTnT, TNNT2). We determined whether TNNT2 mutations cause cardiomyopathies by altering cTnT function or quantity; whether the severity of DCM is related to the ratio of mutant to wildtype cTnT; whether Ca2+ desensitization occurs in DCM; and whether absence of cTnT impairs early embryonic cardiogenesis.\ud Methods and Findings: We ablated Tnnt2 to produce heterozygous Tnnt2+/2 mice, and crossbreeding produced homozygous null Tnnt22/2 embryos. We also generated transgenic mice overexpressing wildtype (TGWT) or DCM mutant (TGK210D) Tnnt2. Crossbreeding produced mice lacking one allele of Tnnt2, but carrying...
Background-In cardiomyocytes from patients with hypertrophic cardiomyopathy, mechanical dysfunction ...
Abstract — Troponin, a contractile protein of the thin filament of striated muscle, consists of thre...
An arginine (R) to a glycine (G) mutation at position 145 in the highly reserved inhibitory domain o...
Hypertrophic (HCM) and dilated (DCM) cardiomyopathies result from sarcomeric protein mutations, incl...
Background: Hypertrophic (HCM) and dilated (DCM) cardiomyopathies results from sarcomeric protein mu...
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardio...
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardio...
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardio...
Key points: Mutations in genes encoding cardiac troponin I (TNNI3) and cardiac troponin T (TNNT2) ca...
AbstractCardiac troponin T (cTnT) is a component of the troponin (Tn) complex in cardiac myocytes, a...
The overarching focus of this thesis is on the molecular underpinnings of inherited cardiomyopathies...
The overarching focus of this thesis is on the molecular underpinnings of inherited cardiomyopathies...
Most studies of the mechanisms leading to hereditary dilated cardiomyopathy (DCM) have been performe...
Familial hypertrophic cardiomyopathy (HCM) is caused by mutations in at least 8 contractile protein ...
Dilated cardiomyopathy (DCM), characterized by ventricular dilation and diminished contractile funct...
Background-In cardiomyocytes from patients with hypertrophic cardiomyopathy, mechanical dysfunction ...
Abstract — Troponin, a contractile protein of the thin filament of striated muscle, consists of thre...
An arginine (R) to a glycine (G) mutation at position 145 in the highly reserved inhibitory domain o...
Hypertrophic (HCM) and dilated (DCM) cardiomyopathies result from sarcomeric protein mutations, incl...
Background: Hypertrophic (HCM) and dilated (DCM) cardiomyopathies results from sarcomeric protein mu...
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardio...
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardio...
Aim: Mutations in a sarcomeric protein can cause hypertrophic cardiomyopathy (HCM) or dilated cardio...
Key points: Mutations in genes encoding cardiac troponin I (TNNI3) and cardiac troponin T (TNNT2) ca...
AbstractCardiac troponin T (cTnT) is a component of the troponin (Tn) complex in cardiac myocytes, a...
The overarching focus of this thesis is on the molecular underpinnings of inherited cardiomyopathies...
The overarching focus of this thesis is on the molecular underpinnings of inherited cardiomyopathies...
Most studies of the mechanisms leading to hereditary dilated cardiomyopathy (DCM) have been performe...
Familial hypertrophic cardiomyopathy (HCM) is caused by mutations in at least 8 contractile protein ...
Dilated cardiomyopathy (DCM), characterized by ventricular dilation and diminished contractile funct...
Background-In cardiomyocytes from patients with hypertrophic cardiomyopathy, mechanical dysfunction ...
Abstract — Troponin, a contractile protein of the thin filament of striated muscle, consists of thre...
An arginine (R) to a glycine (G) mutation at position 145 in the highly reserved inhibitory domain o...